Heart Center, Segeberger Kliniken
Bad Segeberg, 23795, Germany
Location status: Recruiting
NCT Number: NCT03192774
A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Bad Segeberg, 23795, Germany
Location status: Recruiting
A prospective single center registry including all patients treated with transcatheter aortic valve implantation (TAVI) at the Heart Center, Bad Segeberg, Germany. Patients undergo a routine clinical and echocardiographic follow-up schedule, including a long-term follow-up plan beyond 5 years to assess valve durability.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interventional replacement of the aortic valve
Time frame: Up to 10 years
Cardiovascular and not cardiovascular death
Time frame: Up to 10 years
Transprosthetic mean pressure gradient ≥40 mmHg and/or ≥20 mmHg rise from baseline OR severe intraprosthetic aortic regurgitation
Interested in participating?
Request InfoSegeberger Kliniken GmbH
Other
A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg
Acronym: POST-TAVI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715279
AORTIC VALVE DISEASES, Aortic Valve Disease
Chengdu, Sichuan, China
View Trial DetailsNCT06049654
Aortic Valve Disease, Aortic Valve Insufficiency
Alessandria, Italy
View Trial DetailsNCT06596460
Aortic Stenosis, Severe, Aortic Valve Disease
London, England, United Kingdom
View Trial DetailsNCT07008911
Aortic Valve Disease, Aortic Valve Stenosis
Aurora, Colorado, United States
View Trial Details